• bitcoinBitcoin(BTC)$77,235.00-0.15%
  • ethereumEthereum(ETH)$2,501.89-1.18%
  • tetherTether(USDT)$1.00-0.01%
  • binancecoinBNB(BNB)$720.30-1.79%
  • rippleXRP(XRP)$1.35-1.63%
  • usd-coinUSDC(USDC)$1.000.00%
  • solanaSolana(SOL)$100.61-1.36%
  • tronTRON(TRX)$0.3412760.31%
  • Figure HelocFigure Heloc(FIGR_HELOC)$1.00-4.19%
  • zcashZcash(ZEC)$1,097.90-3.63%
  • HyperliquidHyperliquid(HYPE)$78.29-2.35%
  • dogecoinDogecoin(DOGE)$0.083796-1.44%
  • RainRain(RAIN)$0.0153091.78%
  • moneroMonero(XMR)$535.431.48%
  • USDSUSDS(USDS)$1.000.00%
  • whitebitWhiteBIT Coin(WBT)$80.00-0.50%
  • chainlinkChainlink(LINK)$11.33-1.95%
  • leo-tokenLEO Token(LEO)$9.05-0.63%
  • cardanoCardano(ADA)$0.206658-0.73%
  • stellarStellar(XLM)$0.178474-1.88%
  • Ethena USDeEthena USDe(USDE)$1.00-0.02%
  • daiDai(DAI)$1.000.01%
  • bitcoin-cashBitcoin Cash(BCH)$223.87-2.35%
  • USD1USD1(USD1)$1.00-0.02%
  • litecoinLitecoin(LTC)$54.450.77%
  • uniswapUniswap(UNI)$6.26-2.74%
  • the-open-networkGram (prev. Toncoin)(GRAM)$1.36-1.79%
  • CantonCanton(CC)$0.095336-2.79%
  • hedera-hashgraphHedera(HBAR)$0.0756431.14%
  • Global DollarGlobal Dollar(USDG)$1.00-0.01%
  • avalanche-2Avalanche(AVAX)$7.38-0.46%
  • shiba-inuShiba Inu(SHIB)$0.000005-1.55%
  • nearNEAR Protocol(NEAR)$2.29-4.18%
  • suiSui(SUI)$0.71-1.97%
  • crypto-com-chainCronos(CRO)$0.058067-1.73%
  • paypal-usdPayPal USD(PYUSD)$1.00-0.01%
  • BlackRock USD Institutional Digital Liquidity FundBlackRock USD Institutional Digital Liquidity Fund(BUIDL)$1.000.00%
  • tether-goldTether Gold(XAUT)$4,349.640.00%
  • Circle USYCCircle USYC(USYC)$1.140.00%
  • MemeCoreMemeCore(M)$1.14-3.63%
  • Ripple USDRipple USD(RLUSD)$1.00-0.01%
  • okbOKB(OKB)$113.06-0.13%
  • BittensorBittensor(TAO)$234.21-0.54%
  • Ondo US Dollar YieldOndo US Dollar Yield(USDY)$1.15-0.01%
  • aaveAave(AAVE)$125.80-0.17%
  • AsterAster(ASTER)$0.700.41%
  • pax-goldPAX Gold(PAXG)$4,353.57-0.03%
  • mantleMantle(MNT)$0.57-0.62%
  • BitwayBitway(BTW)$0.6922.19%
  • World Liberty FinancialWorld Liberty Financial(WLFI)$0.057003-4.09%
TradePoint.io
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop
No Result
View All Result
TradePoint.io
No Result
View All Result

First over-the-counter birth control pill expected in stores later this month

March 4, 2024
in Business
Reading Time: 4 mins read
A A
First over-the-counter birth control pill expected in stores later this month
ShareShareShareShareShare

The first over-the-counter birth control pill will be available in US stores later this month, allowing American women and teens to purchase contraceptive medication as easily as they buy aspirin.

Manufacturer Perrigo said Monday it has begun shipping the medication, Opill, to major retailers and pharmacies. A one-month supply will cost about $20 and a three-month supply will cost around $50, according to the company’s suggested retail price. It will also be sold online.

YOU MAY ALSO LIKE

New details reveal Leon Black’s friendship with Jeffrey Epstein

Scott Bessent’s attempts to suppress interest rates could spark a recession

The launch has been closely watched since last July, when the Food and Drug Administration said the once-a-day Opill could be sold without a prescription. Ireland-based Perrigo noted there will be no age restrictions on sales, similar to other over-the-counter medications.


A one-month supply will cost about $20 and a three-month supply will cost around $50, according to the company’s suggested retail price. AP

Opill is an older class of contraceptive, sometimes called minipills, that contain a single synthetic hormone, progestin, and generally carry fewer side effects than more popular combination estrogen and progestin pills.

The launch gives US women another birth control option amid the legal and political battles over reproductive health, including the reversal of Roe v. Wade, which has upended abortion access across the US. Opill’s approval is unrelated to the ongoing court battles over the abortion pill mifepristone. And anti-abortion groups have generally emphasized that they do not oppose contraceptives to prevent pregnancies.

Birth control pills are available without a prescription across much of South America, Asia and Africa.

The drug’s approval came despite some concerns by FDA scientists about the company’s results, including whether women with certain medical conditions would understand that they shouldn’t take the drug.

Dr. Verda Hicks, president of the American College of Obstetricians and Gynecologists, in a statement, said studies have shown that patients, including adolescents, can effectively screen themselves to use the pills.

Credit: Source link

ShareTweetSendSharePin

Related Posts

New details reveal Leon Black’s friendship with Jeffrey Epstein
Business

New details reveal Leon Black’s friendship with Jeffrey Epstein

September 13, 2026
Scott Bessent’s attempts to suppress interest rates could spark a recession
Business

Scott Bessent’s attempts to suppress interest rates could spark a recession

September 13, 2026
New In-N-Out Burger teased at popular Salinas mall
Business

New In-N-Out Burger teased at popular Salinas mall

September 12, 2026
More than 2 million sour candy bottles recalled over choking hazard
Business

More than 2 million sour candy bottles recalled over choking hazard

September 12, 2026
Next Post
Couple says they ‘feel broke’ despite making K a month

Couple says they 'feel broke' despite making $70K a month

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

No Result
View All Result
Live Updates: Germany’s Far Right Has Big Lead in Key Election, Exit Polls Show – The New York Times

Live Updates: Germany’s Far Right Has Big Lead in Key Election, Exit Polls Show – The New York Times

September 6, 2026
Trial date set for Nicolás Maduro and his wife

Trial date set for Nicolás Maduro and his wife

September 7, 2026
JUST IN: The Biggest Insider Sale In Company’s HISTORY!?

JUST IN: The Biggest Insider Sale In Company’s HISTORY!?

September 13, 2026

About

Learn more

Our Services

Legal

Privacy Policy

Terms of Use

Bloggers

Learn more

Article Links

Contact

Advertise

Ask us anything

©2020- TradePoint.io - All rights reserved!

Tradepoint.io, being just a publishing and technology platform, is not a registered broker-dealer or investment adviser. So we do not provide investment advice. Rather, brokerage services are provided to clients of Tradepoint.io by independent SEC-registered broker-dealers and members of FINRA/SIPC. Every form of investing carries some risk and past performance is not a guarantee of future results. “Tradepoint.io“, “Instant Investing” and “My Trading Tools” are registered trademarks of Apperbuild, LLC.

This website is operated by Apperbuild, LLC. We have no link to any brokerage firm and we do not provide investment advice. Every information and resource we provide is solely for the education of our readers. © 2020 Apperbuild, LLC. All rights reserved.

No Result
View All Result
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop

© 2023 - TradePoint.io - All Rights Reserved!